if AKI was attributed to urinary tract obstruction, if there was
an episode of AKI in the eight weeks prior to enrollment, if the
white blood count was < 3.0 x 109/L, if patients had received
chemotherapy in the 30 days prior to enrollment, if patients
had received hematopoietic cytokines in the 14 days prior to
enrollment,